The Antacid Market is witnessing steady growth as consumers increasingly seek convenient solutions for heartburn, indigestion, acid reflux, and other gastrointestinal symptoms. According to Market Research Future, the market was valued at USD 7.54 billion in 2025 and is projected to reach USD 10.84 billion by 2035, registering a CAGR of 3.70% during 2026–2035.
The increasing prevalence of lifestyle-related gastrointestinal disorders is a major factor supporting market expansion. Sedentary lifestyles, high-fat diets, irregular eating patterns, and stress are contributing to digestive discomfort and increasing demand for over-the-counter remedies. Tablets currently represent the leading formulation category, while gummies and chewable formats are gaining popularity among consumers seeking convenient and palatable options.
Calcium carbonate remains an important active ingredient because of its affordability and widespread consumer familiarity. At the same time, alginate-based formulations are emerging as a fast-growing category because they provide a physical barrier over gastric contents.
North America currently accounts for the largest regional share, while Asia-Pacific is expected to experience rapid growth due to expanding pharmacy networks, urbanization, and rising healthcare spending. E-commerce is also transforming distribution, providing consumers with convenient access and subscription-based purchasing options.
Overall, product innovation, digital distribution, changing consumer preferences, and increasing awareness of digestive health are expected to support the continued development of the global antacid industry.